Other
OncoLize raising Series A round of €8.5 Million to treat aggressive tumors
OncoLize is preparing first clinical trials to treat pancreatic tumors. Based on solid Proof-of-Concept data and its proprietary OCL platform the company will raise €8.5 Million in two steps. This will start trials in the Read more…